Individualizing the Current Adjuvant Therapy Algorithm for Patients With HR+/HER2- EBC

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Individualizing Therapy for Patients With HR+/HER2- MBC

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Managing AEs With CDK4/6 Inhibitors to Promote Adherence and Persistence to Oral Therapy in Your Practice

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

0.50
Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Estrogen Receptor Mutations in HR+ Breast Cancer: Next-Generation Practice Recommendations on Mutation Screening to Guide Therapeutic Decisions

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.25
Improving Outcomes in Patients With High-risk Breast Cancer: Outcomes and Analysis From an Educational Program on HR+/HER2- Early and Metastatic Breast Cancer

Content Format:

PDF

Credit Type:

--

Credits:

--
Managing AEs With CDK4/6 Inhibitors to Promote Adherence and Persistence to Oral Therapy in Your Practice

Content Format:

Slideset

Credit Type:

ABIM MOC | AMA

Credits:

0.25
Managing AEs With Oral SERDs for Patients With HR+/HER2- Metastatic Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Integrating Oral SERDs Into Treatment for Patients With HR-positive/HER2-negative Metastatic Breast Cancer and Current Rationale or Medical Need

Content Format:

Slideset

Credit Type:

--

Credits:

--
Discussing Newer Treatment Options and What to Expect With Patients With High-Risk HR+/HER2- Early Breast Cancer

Content Format:

Video

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.25
Adjuvant Therapy for HER2-Negative Early Breast Cancer: Interactive Decision Support Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Guidance on Treating HR+/HER2- Breast Cancer to Improve Outcomes

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Making Treatment Decisions for Metastatic Breast Cancer: An Interactive Decision Support Tool for Patients

Content Format:

Tool

Credit Type:

--

Credits:

--
Improving Outcomes in Patients With High-Risk Breast Cancer: Expert Guidance and Team Training for HR-Positive/HER2-Negative Disease

Content Format:

Slideset

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Treatment Guidance for Metastatic Breast Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--
As the Treatment of HER2-Negative Early Breast Cancer Evolves, So Does Our Corresponding Treatment Decision Support Tool

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
(Neo)Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Improving Outcomes in HER2-Negative Early Breast Cancer With Individualized Targeted Approaches

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer

Content Format:

Video

Credit Type:

AAPA | ANCC

Credits:

1.00
Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
A 44-Year-Old Patient With Rapidly Progressing Metastatic TNBC Who Receives Sacituzumab Govitecan

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Latest Insights on Ki-67 Use in HR-Positive/HER2-Negative Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
(Neo) Adjuvant Therapy in HER2-Negative Early Breast Cancer Treatment Selection Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Key Updates in the Treatment of Hormone Receptor–Positive Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expanding the Scope of Precision Care for Patients With HR-Positive Breast Cancers: Things You Should Know

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Practical Management of Adverse Events and Strategies to Promote Adherence with Targeted Therapies in HR-Positive Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
What to Know About the New Approval for Abemaciclib in Patients With Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
An Interactive Tool for Managing AEs With Oral Targeted Therapies for HR+, HER2– Breast Cancer

Content Format:

Tool

Credit Type:

--

Credits:

--